Biopharma Launches Trial Testing Nitric Oxide as COVID-19 Treatment: https://t.co/zutSptxyJ4

The design, timeline and takeaways of Beyond Air's study are presented in a ROTH Capital Partners report.

$XAIR #covid19 #healthcare #stocks  @BeyondAirInc https://t.co/FKejEJweQq